Severe de novo Ulcerative Colitis following Ixekizumab Therapy.

Philipose, Jobin; Ahmed, Moiz; Idiculla, Pretty S; Mulrooney, Stephen M; Gumaste, Vivek V

Philipose, Jobin; Ahmed, Moiz; Idiculla, Pretty S; Mulrooney, Stephen M; Gumaste, Vivek V.

Afiliación

Philipose J; Department of Internal Medicine, Staten Island University Hospital, Northwell Health, New York, New York, USA.
Ahmed M; Department of Gastroenterology, Mount Sinai School of Medicine, Elmhurst Hospital Center, New York, New York, USA.
Idiculla PS; Sree Gokulam Medical College and Research Foundation, Trivandrum, India.
Mulrooney SM; Department of Gastroenterology, Staten Island University Hospital, Northwell Health, New York, New York, USA.
Gumaste VV; Department of Gastroenterology, Staten Island University Hospital, Northwell Health, New York, New York, USA.

Case Rep Gastroenterol ; 12(3): 617-621, 2018.

Article en En | MEDLINE | ID: mdl-30483039

Palabras clave

Inflammatory bowel disease; Ixekizumab; Ulcerative colitis

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Clinical_trials Idioma: En Revista: Case Rep Gastroenterol Año: 2018 Tipo del documento: Article País de afiliación: Estados Unidos Pais de publicación: Suiza

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google